Risk of New-Onset Hair Loss with Semaglutide and Tirzepatide: A TriNetX Cohort Study - PubMed
2 days ago
- #Hair loss
- #Alopecia
- #GLP-1 receptor agonist
- Study examines the risk of new-onset hair loss with Semaglutide and Tirzepatide.
- Research conducted using a TriNetX cohort study methodology.
- Keywords include Alopecia, Androgenetic alopecia, and Telogen effluvium.
- Electronic health records were utilized in the study.
- Focus on GLP-1 receptor agonists and their association with hair loss.